Ameritox Appoints New Chief Medical Officer

October 16, 2014

Brings 25 years of clinical and leadership experience to Ameritox brands

BALTIMORE – October 16, 2014 — AmeritoxSM, the nation’s leader in medication monitoring solutions, today announced the appointment of Thomas Smith, M.D., as Chief Medical Officer. In this role, Smith will lead a field-based team offering scientific resources for healthcare providers, patients and managed care plans.

Smith has held leadership positions at a variety of healthcare companies that have provided him with experiences that will benefit both the pain and behavioral health sides of Ameritox’s business. He most recently served as CMO for Mallinckrodt Pharmaceuticals, where he helped the company serve millions of patients around the world with effective and safe medications while helping to quickly grow the company’s market capitalization from $2 billion to $8 billion. He has also held clinical leadership roles at Abbott Laboratories, Teva Pharmaceuticals, Kendle International, Akros Pharma and Genzyme. In addition to vast expertise in Medical Affairs, Smith has led clinical development programs across all phases for the Food and Drug Administration and European Medicines Agency registration in a broad range of therapeutic areas. He also brings critical knowledge of working face-to-face with patients to Ameritox, having practiced family medicine for 12 years before moving to the clinical research side.

“With his well-rounded experience, Tom will greatly help us continue to advance our mission of improving the quality of patient care and preventing human tragedy. We’re proud to have him aboard,” said Scott Walton, CEO of Ameritox.

“Working for Ameritox, I’ll be able to go home each night knowing that we’ve helped provide information to physicians and healthcare workers to help ensure that patients are being effectively treated and are using their prescription drugs appropriately. That’s some real peace of mind,” said Smith.

About Ameritox

Ameritox helped pioneer the prescription drug monitoring necessary to address the national epidemic of prescription drug misuse, abuse, and diversion. As the nation’s trusted leader in Pain Medication Monitoring SolutionsSM, Ameritox provides medical and business professionals with data-driven analysis and tailored solutions that can improve patient care and prevent tragedy. Ameritox, headquartered in Baltimore, Md., has 800 employees nationwide and laboratory facilities in Greensboro, N.C.

Visit the Ameritox website at: www.ameritox.com
Follow Ameritox on Twitter: www.twitter.com/ameritox
Watch Ameritox on YouTube: www.youtube.com/ameritox

Contacts:
Lon Wagner, Ameritox
Office: 336-387-7742
lon.wagner@ameritox.com

Genevieve Rozansky, 30 Point Strategies
Office: 202-509-0794
genevieve@30point.com